BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17194554)

  • 1. Use of hormone replacement therapy (HRT) among women aged 45-64 years in the German EPIC-cohorts.
    Nagel G; Lahmann PH; Schulz M; Boeing H; Linseisen J
    Maturitas; 2007 Apr; 56(4):436-46. PubMed ID: 17194554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle factors and choice of hormone replacement therapy among Danish nurses.
    Hundrup YA; Thoning H; Obel EB; Rasmussen NK; Philip J
    Scand J Public Health; 2002; 30(1):47-53. PubMed ID: 11928833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
    Lucas R; Barros H
    Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997.
    van Duijnhoven FJ; van Gils CH; Bezemer ID; Peeters PH; van der Schouw YT; Grobbee DE
    Maturitas; 2006 Mar; 53(4):462-75. PubMed ID: 16198516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in Denmark, 1995-2004.
    Løkkegaard E; Lidegaard O; Møller LN; Agger C; Andreasen AH; Jørgensen T
    Acta Obstet Gynecol Scand; 2007; 86(11):1342-51. PubMed ID: 17963062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.
    Du Y; Melchert HU; Schäfer-Korting M
    Maturitas; 2005; 52(3-4):223-34. PubMed ID: 16040212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and correlates of hormone replacement therapy use among middle-aged Australian women.
    France K; Schofield MJ; Lee C
    Womens Health; 1997; 3(2):121-38. PubMed ID: 9332154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
    Wise MR; Stewart DE; Liu P; Abramson BL
    CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes.
    Schulze MB; Hoffmann K; Boeing H; Linseisen J; Rohrmann S; Möhlig M; Pfeiffer AF; Spranger J; Thamer C; Häring HU; Fritsche A; Joost HG
    Diabetes Care; 2007 Mar; 30(3):510-5. PubMed ID: 17327313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage].
    Bergmann MM; Noethlings U; Eisinger B; Streller B; Quehl A; Walter D; Lahmann PH; Boeing H
    Gesundheitswesen; 2004; 66(8-9):475-81. PubMed ID: 15372347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
    Lundberg V; Tolonen H; Stegmayr B; Kuulasmaa K; Asplund K;
    Maturitas; 2004 May; 48(1):39-49. PubMed ID: 15223107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with intention to use hormone replacement therapy among Thai middle-aged women.
    Burusanont M; Hadsall RS
    Maturitas; 2004 Mar; 47(3):219-27. PubMed ID: 15036492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.